Squalamine for the Treatment in Proliferative Diabetic Retinopathy
NCT01769183
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Retinal Neovascularization
Interventions
DRUG:
Squalamine Lactate ophthalmic solution 0.2%
Sponsor
Elman Retina Group